VCL — Vaxtex Cotfab Income Statement
0.000.00%
- IN₹402.42m
- IN₹499.19m
- IN₹52.53m
- 20
- 17
- 94
- 38
Annual income statement for Vaxtex Cotfab, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 262 | 619 | 756 | 166 | 52.5 |
| Cost of Revenue | |||||
| Gross Profit | 42.6 | 78.6 | 53.1 | -52.5 | 1.98 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 249 | 592 | 747 | 259 | 58.6 |
| Operating Profit | 12.8 | 27.1 | 8.95 | -92.9 | -6.05 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2.63 | 20.1 | 11.6 | -88.3 | 4.12 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.78 | 14.9 | 11.3 | -88.3 | 8.84 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.78 | 14.9 | 11.3 | -88.3 | 8.84 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.78 | 14.9 | 11.3 | -88.3 | 8.84 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.141 | 0.141 | 0.011 | -0.587 | 0.048 |